These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 4197928)
1. Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Streeter DG; Witkowski JT; Khare GP; Sidwell RW; Bauer RJ; Robins RK; Simon LN Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1174-8. PubMed ID: 4197928 [TBL] [Abstract][Full Text] [Related]
2. In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Huffman JH; Sidwell RW; Khare GP; Witkowski JT; Allen LB; Robins RK Antimicrob Agents Chemother; 1973 Feb; 3(2):235-41. PubMed ID: 4208281 [TBL] [Abstract][Full Text] [Related]
3. Nuclear magnetic resonance studies of the solution properties of the antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, the coresponding 5'-phosphate, and related triazole nucleosides. Dea P; Schweizer MP; Kreishman GP Biochemistry; 1974 Apr; 13(9):1862-7. PubMed ID: 4840830 [No Abstract] [Full Text] [Related]
4. Inhibition of vaccinia virus growth by the nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ribavirin). Katz E; Margalith E; Winer B J Gen Virol; 1976 Aug; 32(2):327-30. PubMed ID: 1018177 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of certain 1,2,3-triazole carboxamide nucleosides related to bredinin and pyrazofurin. Revankar GR; Solan VC; Robins RK; Witkowski JT Nucleic Acids Symp Ser; 1981; (9):65-8. PubMed ID: 6117831 [TBL] [Abstract][Full Text] [Related]
7. The importance of IMP dehydrogenase inhibition in the broad spectrum antiviral activity of ribavirin and selenazofurin. Robins RK; Revankar GR; McKernan PA; Murray BK; Kirsi JJ; North JA Adv Enzyme Regul; 1985; 24():29-43. PubMed ID: 2872781 [TBL] [Abstract][Full Text] [Related]
8. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase. Sokoloski JA; Blair OC; Sartorelli AC Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796 [TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of subacute sclerosing panencephalitis virus by the antiviral agent ribavirin. Murphy MF J Infect Dis; 1978 Aug; 138(2):249-51. PubMed ID: 79625 [TBL] [Abstract][Full Text] [Related]
10. Inosine 5'-monophosphate dehydrogenase of Escherichia coli K12: the nature of the inhibition by guanosine 5'-monophosphate. Lambden PR; Drabble WT Biochem J; 1973 Jul; 133(3):607-8. PubMed ID: 4354743 [TBL] [Abstract][Full Text] [Related]
11. Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice. Khare GP; Sidwell RW; Witkowski JT; Simon LN; Robins RK Antimicrob Agents Chemother; 1973 Apr; 3(4):517-22. PubMed ID: 4790606 [TBL] [Abstract][Full Text] [Related]
12. Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling. Krajczyk A; Kulinska K; Kulinski T; Hurst BL; Day CW; Smee DF; Ostrowski T; Januszczyk P; Zeidler J Antivir Chem Chemother; 2014 Jan; 23(4):161-71. PubMed ID: 23538746 [TBL] [Abstract][Full Text] [Related]
13. In vitro effect of virazole against influenza viruses. Togo Y Antimicrob Agents Chemother; 1973 Dec; 4(6):641-2. PubMed ID: 4793883 [TBL] [Abstract][Full Text] [Related]
14. Increased sensitivity to oxanosine, a novel nucleoside antibiotic, of rat kidney cells upon expression of the integrated viral src gene. Uehara Y; Hasegawa M; Hori M; Umezawa H Cancer Res; 1985 Nov; 45(11 Pt 1):5230-4. PubMed ID: 2413989 [TBL] [Abstract][Full Text] [Related]
15. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents. Franchetti P; Grifantini M Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603 [TBL] [Abstract][Full Text] [Related]
16. Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals. Sidwell RW; Allen LB; Khare GP; Huffman JH; Witkowski JT; Simon LN; Robins RK Antimicrob Agents Chemother; 1973 Feb; 3(2):242-6. PubMed ID: 4790589 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. Witkowski JT; Robins RK; Sidwell RW; Simon LN J Med Chem; 1972 Nov; 15(11):1150-4. PubMed ID: 4347550 [No Abstract] [Full Text] [Related]
18. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus. Ölschläger S; Neyts J; Günther S Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate. Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204 [TBL] [Abstract][Full Text] [Related]